JP2005504018A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005504018A5 JP2005504018A5 JP2003510066A JP2003510066A JP2005504018A5 JP 2005504018 A5 JP2005504018 A5 JP 2005504018A5 JP 2003510066 A JP2003510066 A JP 2003510066A JP 2003510066 A JP2003510066 A JP 2003510066A JP 2005504018 A5 JP2005504018 A5 JP 2005504018A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- patient
- agent
- toxin
- bound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 4
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 3
- 230000001461 cytolytic effect Effects 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 238000002560 therapeutic procedure Methods 0.000 claims 3
- 239000003053 toxin Substances 0.000 claims 3
- 231100000765 toxin Toxicity 0.000 claims 3
- 208000034578 Multiple myelomas Diseases 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 230000002435 cytoreductive effect Effects 0.000 claims 1
- 230000003394 haemopoietic effect Effects 0.000 claims 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 1
- 238000010253 intravenous injection Methods 0.000 claims 1
- 201000000050 myeloid neoplasm Diseases 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR6179A AUPR617901A0 (en) | 2001-07-06 | 2001-07-06 | Method for treating multiple myeloma |
| PCT/AU2002/000896 WO2003004056A1 (en) | 2001-07-06 | 2002-07-05 | Method for treating multiple myeloma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005504018A JP2005504018A (ja) | 2005-02-10 |
| JP2005504018A5 true JP2005504018A5 (enExample) | 2005-10-27 |
| JP4535424B2 JP4535424B2 (ja) | 2010-09-01 |
Family
ID=3830143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003510066A Expired - Lifetime JP4535424B2 (ja) | 2001-07-06 | 2002-07-05 | 多発性骨髄腫の治療法 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US7344715B2 (enExample) |
| EP (1) | EP1414492B1 (enExample) |
| JP (1) | JP4535424B2 (enExample) |
| CN (1) | CN1551783B (enExample) |
| AU (1) | AUPR617901A0 (enExample) |
| CA (1) | CA2461989C (enExample) |
| DE (1) | DE60223688T2 (enExample) |
| DK (1) | DK1414492T3 (enExample) |
| ES (1) | ES2296952T3 (enExample) |
| MX (1) | MXPA04000130A (enExample) |
| NZ (1) | NZ530099A (enExample) |
| WO (1) | WO2003004056A1 (enExample) |
| ZA (1) | ZA200400959B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR617901A0 (en) * | 2001-07-06 | 2001-08-02 | Pacmab Pty Ltd | Method for treating multiple myeloma |
| CA2557482C (en) * | 2004-02-27 | 2018-01-16 | Pacmab Limited | Target for b-cell disorders |
| ATE503187T1 (de) * | 2004-12-23 | 2011-04-15 | Hoffmann La Roche | Nachweis eines therapeutischen antikörpers in einem versuchstier |
| GB0608444D0 (en) * | 2006-04-27 | 2006-06-07 | Binding Site The Ltd | Dialysis |
| EP2246427B1 (en) | 2008-02-08 | 2016-11-30 | Immunas Pharma, Inc. | Antibodies capable of binding specifically to amyloid beta-oligomers, and use thereof |
| US9085614B2 (en) | 2008-08-01 | 2015-07-21 | Immunas Pharma, Inc. | Antibodies that specifically bind to Aβ oligomers and uses thereof |
| SG10201401310VA (en) * | 2009-04-07 | 2014-06-27 | Immune System Therapeutics Ltd | Method for treating immune disorders |
| WO2010119704A1 (en) | 2009-04-17 | 2010-10-21 | Immunas Pharma, Inc. | Antibodies that specifically bind to a beta oligomers and use thereof |
| DK2462161T3 (en) | 2009-08-06 | 2017-06-06 | Immunas Pharma Inc | Antibodies specifically binding to A-beta oligomers and their use |
| DK2462162T3 (en) | 2009-08-06 | 2017-01-16 | Immunas Pharma Inc | Antibodies that specifically bind to A-beta oligomers and their use |
| CN102241773B (zh) * | 2010-05-13 | 2014-05-14 | 四川大学 | 抗骨髓瘤细胞多克隆抗体及其制备方法 |
| WO2012022682A1 (en) | 2010-08-17 | 2012-02-23 | F. Hoffmann-La Roche Ag | Anti-human igg1 antibody |
| AU2013204922B2 (en) | 2012-12-20 | 2015-05-14 | Celgene Corporation | Chimeric antigen receptors |
| CA2907397C (en) | 2013-03-15 | 2022-11-22 | Anthrogenesis Corporation | Modified t lymphocytes |
| RU2743188C2 (ru) | 2015-04-23 | 2021-02-16 | Хемалоджикс Пти. Лтд. | Химерные антигенные рецепторы к каппа-антигену миеломы и варианты их применения |
| CN109498799A (zh) * | 2016-03-13 | 2019-03-22 | 曹帅 | 一种用于治疗骨髓增生、骨癌的药物组合物及其用途 |
| WO2018075820A2 (en) | 2016-10-20 | 2018-04-26 | Celgene Corporation | Cereblon-based heterodimerizable chimeric antigen receptors |
| EP3890780A4 (en) * | 2018-12-03 | 2022-08-17 | HaemaLogiX Pty Ltd. | METHOD OF TREATMENT |
| US20240262928A1 (en) * | 2020-03-27 | 2024-08-08 | Haemalogix Pty Ltd | Composition and Method |
| JP2023085151A (ja) * | 2021-12-08 | 2023-06-20 | 株式会社八神製作所 | 体外ホウ素中性子反応を用いた幹細胞の分取方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5859205A (en) * | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| AUPR617901A0 (en) * | 2001-07-06 | 2001-08-02 | Pacmab Pty Ltd | Method for treating multiple myeloma |
-
2001
- 2001-07-06 AU AUPR6179A patent/AUPR617901A0/en not_active Abandoned
-
2002
- 2002-07-05 MX MXPA04000130A patent/MXPA04000130A/es active IP Right Grant
- 2002-07-05 CA CA2461989A patent/CA2461989C/en not_active Expired - Lifetime
- 2002-07-05 US US10/481,212 patent/US7344715B2/en not_active Expired - Lifetime
- 2002-07-05 CN CN028174437A patent/CN1551783B/zh not_active Expired - Lifetime
- 2002-07-05 WO PCT/AU2002/000896 patent/WO2003004056A1/en not_active Ceased
- 2002-07-05 DK DK02742531T patent/DK1414492T3/da active
- 2002-07-05 EP EP02742531A patent/EP1414492B1/en not_active Expired - Lifetime
- 2002-07-05 ES ES02742531T patent/ES2296952T3/es not_active Expired - Lifetime
- 2002-07-05 NZ NZ530099A patent/NZ530099A/en not_active IP Right Cessation
- 2002-07-05 JP JP2003510066A patent/JP4535424B2/ja not_active Expired - Lifetime
- 2002-07-05 DE DE60223688T patent/DE60223688T2/de not_active Expired - Lifetime
-
2004
- 2004-02-05 ZA ZA2004/00959A patent/ZA200400959B/en unknown
-
2008
- 2008-01-18 US US12/016,470 patent/US7556803B2/en not_active Expired - Lifetime
- 2008-01-18 US US12/016,462 patent/US7838041B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123084T1 (el) | Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι | |
| CA2350064A1 (en) | Chimeric anti-cd20 antibody treatment of patients receiving bmt or pbsc transplants | |
| EA200000468A1 (ru) | Терапевтическая композиция для введения толтеродина с контролируемым высвобождением | |
| WO2003039436A3 (es) | Composiciones farmaceuticas que contienen oxibutinina | |
| ATE396967T1 (de) | (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten | |
| CA2590159A1 (en) | Regimens for intra-articular viscosupplementation | |
| CA2461989A1 (en) | Method for treating multiple myeloma | |
| ATE491715T1 (de) | Oligoribonukleotide und verfahren zu deren anwendung bei der behandlung von fibrotischen leiden und anderen krankheiten | |
| IL160894A0 (en) | Combination of selected opioids with muscarine antagonists for treating urinary incontinence | |
| DE59600683D1 (de) | Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten | |
| DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme | |
| JP4846151B2 (ja) | 骨髄もしくは血液幹細胞の移植前の患者のコンディショニングのためのトレオスルファンの使用 | |
| Iguchi et al. | Plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis of kidney allograft in adult recipients | |
| DK1830857T3 (da) | Beclomethasondipropionat og prednison til reducering af dødelighed associeret med Graft-Versus-Host sygdom | |
| EP0753309A2 (en) | Preparation of lactoferrin (or analogous proteins) and desferrioxamine methanesulfonate (or other metal ion chelators) for the therapy of viral infectious diseases | |
| WO2007011960A3 (en) | Methods and agents to treat autoimmune diseases | |
| RU99108641A (ru) | Препарат и способ лечения эпилепсии и шизофрении | |
| RU2004106095A (ru) | Способ лечения открытой компрессионной травмы мягких тканей конечности | |
| Kudryavtseva et al. | The use of artrofoon in the treatment of ankylosing spondyloarthritis | |
| RU99114404A (ru) | Способ лечения увеитов | |
| RU2005111607A (ru) | Способ лечения рубцов | |
| RU2008105751A (ru) | Способ лечения прогрессирующей (активной) формы субмакулярной неоваскулярной мембраны (снм) | |
| RU2005106577A (ru) | Средство для лечения и профилактики острого панкреатита и способы его применения | |
| NZ775405B2 (en) | Humanized antibodies against c-kit | |
| RU2001113054A (ru) | Способ лечения послеродового острого гнойно-катарального эндометрита коров |